Leukemia, Myelocytic, Acute
Item
histologically confirmed acute myeloid leukemia
boolean
C0023467 (UMLS CUI [1])
Newly Diagnosed Disease
Item
newly diagnosed disease
boolean
C1334965 (UMLS CUI [1])
Chromosome Aberrations | Cytogenetic Analysis | Fluorescent in Situ Hybridization
Item
presence of cytogenetic abnormalities must be determined by standard cytogenetics with or without fish studies
boolean
C0008625 (UMLS CUI [1])
C0752095 (UMLS CUI [2])
C0162789 (UMLS CUI [3])
Leukemic Blast Count peripheral blood
Item
leukemic blast count > 5,000/mm³ of peripheral blood
boolean
C2697913 (UMLS CUI [1,1])
C0229664 (UMLS CUI [1,2])
Acute Promyelocytic Leukemia
Item
no acute promyelocytic leukemia (m3)
boolean
C0023487 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-3
boolean
C1520224 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 2.0 times upper limit of normal (uln)
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
ast < 3.0 times uln
boolean
C0201899 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine < 1.5 times uln
boolean
C0201976 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Mental disorder Uncontrolled Excludes Protocol Compliance
Item
no uncontrolled psychiatric illness that, in the opinion of the principal investigator, would preclude study compliance
boolean
C0004936 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
Comorbidity Excludes Protocol Compliance
Item
no other concurrent medical condition that would preclude study compliance
boolean
C0009488 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Hypersensitivity Investigational New Drugs | Hypersensitivity Antineoplastic Agents
Item
no allergies to any investigational drugs and/or chemotherapeutic agents
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0003392 (UMLS CUI [2,2])
Upper gastrointestinal hemorrhage | Lower gastrointestinal hemorrhage
Item
no upper or lower gastrointestinal (gi) related hemorrhage within the past 6 months as determined by endoscopy
boolean
C0041909 (UMLS CUI [1])
C0024050 (UMLS CUI [2])
Gastrointestinal Hemorrhage Requirement Blood Transfusion
Item
no clinical diagnosis of gi bleeding requiring blood transfusions
boolean
C0017181 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0005841 (UMLS CUI [1,3])
Comorbidity
Item
prior concurrent therapy:
boolean
C0009488 (UMLS CUI [1])
Neoadjuvant Therapy
Item
no prior induction therapy
boolean
C0600558 (UMLS CUI [1])
Prior Chemotherapy Acute leukemia
Item
no prior chemotherapy for acute leukemia
boolean
C1514457 (UMLS CUI [1,1])
C0085669 (UMLS CUI [1,2])
Pharmaceutical Preparations Exclude Protocol Compliance
Item
no concurrent medications that would preclude study compliance
boolean
C0013227 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])